(Q46122546)

19 December 2017

title

A new immunomodulatory therapy for severe sepsis: Ulinastatin Plus Thymosin {alpha} 1. (English)

1 reference

19 December 2017

0 references

Li Yumin

1

1 reference

19 December 2017

Chen Hao

2

1 reference

19 December 2017

Li Xun

3

1 reference

19 December 2017

Zhou Wence

4

1 reference

19 December 2017

He Minyan

5

1 reference

19 December 2017

M Chiriva-Internati

6

1 reference

19 December 2017

M S Wachtel

7

1 reference

19 December 2017

E E Frezza

8

1 reference

19 December 2017

publication date

25 November 2008

1 reference

19 December 2017

Journal of Intensive Care Medicine

published in

1 reference

19 December 2017

volume

24

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

47-53

1 reference

19 December 2017

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

The dynamics of disease progression in sepsis: Markov modeling describing the natural history and the likely impact of effective antisepsis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Current epidemiology of septic shock: the CUB-Réa Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Prevention of infection in multiple trauma patients by high-dose intravenous immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Such stuff as dreams are made on: mediator-directed therapy in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Antiviral therapy of HBV- and HCV-induced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Immunomodulatory function of orally administered thymosin alpha1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

TIR domain-containing adaptors define the specificity of TLR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Mini-review: the role of peptidoglycan recognition in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Peptidoglycan recognition proteins (PGRPs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Protective role of phospholipid oxidation products in endotoxin-induced tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066608326970

Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001958

Identifiers

DOI

10.1177/0885066608326970

1 reference

19 December 2017

1 reference

19 December 2017